Atara Biotherapeutics
ATRA
NASDAQ
IPO2014
about ATRA
Atara Biotherapeutics is a biotechnology company dedicated to creating cutting-edge therapies for oncology and other critical medical conditions to enhance patient outcomes.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $5.62 | $6.51 | $5.58 | $98.56M | 3.42M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$0.32 | 14.43 | 24.94 | -103.50% | -124.62% | 0% |